CORPORATE INTEGRITY AGREEMENT BETWEEN THE OFFICE OF INSPECTOR GENERAL OF THE DEPARTMENT OF HEALTH AND HUMAN SERVICES AND INDIVIOR INC.Corporate Integrity Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations
Contract Type FiledNovember 22nd, 2022 Company Industry
CREDIT AGREEMENT Dated as of December 19, 2014 as amended as of March 16, 2015 as further amended as of December 18, 2017 as further amended as of June 30, 2021 and as further amended as of April 27, 2022 among INDIVIOR FINANCE S.À R.L., as a Term...Credit Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations • New York
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionCREDIT AGREEMENT, dated as of December 19, 2014 and as amended as of March 16, 2015, as further amended as of December 18, 2017 and as further amended as of June 30, 2021 (this “Agreement”), by and among Indivior Finance S.à r.l., a private limited liability company (société à responsabilité limitée) incorporated under the laws of the Grand Duchy of Luxembourg, having its registered office at 21, rue de Fort Elisabeth, L-1463 Luxembourg, Grand Duchy of Luxembourg, registered with the Luxembourg Trade and Companies Register (R.C.S. Luxembourg) under number B 191.812 (the “Lux Borrower”), Indivior SMTM LLC, a limited liability company organized under the laws of Delaware (the “US Co-Borrower”), RBP Global Holdings Limited, a limited company organized under the laws of England and Wales (the “Borrower Representative” or the “Revolver Borrower”, and together with the Term Borrowers (as defined below), the “Borrowers” and each a “Borrower”), the other Loan Parties from time to time party he
October 3, 2022Deposit Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations
Contract Type FiledNovember 22nd, 2022 Company Industry
FORM OF CONTINGENT VALUE RIGHTS AGREEMENTContingent Value Rights Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionTHIS CONTINGENT VALUE RIGHTS AGREEMENT, dated as of [l], (this “Agreement”), is entered into by and between Indivior Inc., a Delaware corporation (“Parent”), and [RIGHTS AGENT], a [l], as Rights Agent (the “Rights Agent”).
DATED 1 DECEMBER 2014 RECKITT BENCKISER HEALTHCARE (UK) LIMITED and RB PHARMACEUTICALS LIMITED LEASE of land and buildings at Dansom Lane, Hull HU8 7DSLease • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations • England and Wales
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionLR1. Date of lease : 1 December 2014 LR2. Title number(s) : LR2.1 Landlord’s title number(s)HS304843, HS286962, HS321544 LR2.2 Other title numbersHS210510, HS341298, HS189949 LR3. Parties to this Lease : LandlordRECKITT BENCKISER HEALTHCARE (UK) LIMITED (registered in England number 00261312) whose registered office is at 103-105 Bath Road, Slough, Berkshire SL1 3UH TenantRB PHARMACEUTICALS LIMITED (registered in England number 07183451) whose registered office is at 103-105 Bath Road, Slough, Berkshire SL1 3UH Other partiesNone LR4. Property : The land and buildings at Dansom Lane, Hull HU8 7DS as registered at the Land Registry under title numbers HS304843, HS286962 and HS321544 shown edged red on the Plan.In the case of a conflict between this clause and the remainder of this Lease then, for the purposes of registration, this clause shall prevail. LR5. Prescribed statements etc. : None LR6. Term for which the Property is leased : The Term is as follows.150 years commencing on and in
AGREEMENT AND PLAN OF MERGER by and among INDIVIOR INC., OLIVE ACQUISITION SUBSIDIARY, INC. and OPIANT PHARMACEUTICALS, INC. dated as of November 13, 2022Merger Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations • Delaware
Contract Type FiledNovember 22nd, 2022 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER (this “Agreement”), dated as of November 13, 2022, is by and among INDIVIOR INC., a Delaware corporation (“Parent”), OLIVE ACQUISITION SUBSIDIARY, INC., a Delaware corporation and a wholly owned subsidiary of Parent (“Merger Sub”), and OPIANT PHARMACEUTICALS, INC., a Delaware corporation (the “Company”). All capitalized terms used in this Agreement shall have the meanings ascribed to such terms in Section 9.5 or as otherwise defined elsewhere in this Agreement unless the context clearly provides otherwise. Parent, Merger Sub and the Company are each sometimes referred to as a “Party” and collectively as the “Parties.”
Indivior PLC Letter AgreementLetter Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations
Contract Type FiledNovember 22nd, 2022 Company Industry
UNITED STATES DISTRICT COURT WESTERN DISTRICT OF VIRGINIA ABINGDONResolution Agreement • November 22nd, 2022 • Indivior PLC • Pharmaceutical preparations
Contract Type FiledNovember 22nd, 2022 Company IndustryUNITED STATES OF AMERICA ) ) v. ) ) Case No. 1:19cr00016 INDIVIOR INC. (a/k/a Reckitt ) Benckiser Pharmaceuticals Inc.) and ) INDIVIOR PLC, ) Defendants )